Skip to main content
. 2022 Feb 25;16:531–540. doi: 10.2147/OPTH.S345403

Figure 1.

Figure 1

PRISMA flow diagram. aIncludes articles reporting epidemiology, treatment methodology, quality of life, and economic analyses. bNo data on VA or number of injections after 12 months of treatment. cTotal number of individual treatment arms for which data were reported.

Abbreviations: PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses; RAP, retinal angiomatous proliferation; VA, visual acuity.